TORONTO – Seven years after setting up shop in downtown Toronto, high resolution, surgical imaging med-tech company Perimeter Medical Imaging Inc. (PMI) is still wrestling with a statistical heartbreaker: 1 in 4 patients told to return for a second surgery to remove cancerous breast tissue after the first surgery failed to get it all. Now PMI has said it can cut that number down dramatically thanks to a $7.44 million investment from the Austin, Texas-based Cancer Prevention and Research Institute of Texas (CPRIT) to identify wayward breast cancer cells using artificial intelligence technology.

Med-tech firms raising money in public or private financings, including: Bigfoot Biomedical, Know Labs, Labminds, Orasure Technologies, Re-Vana Therapeutics, Tae Life Sciences.

Biopharmas raising money in public or private financings, including: Adaptimmune, Allogene, Applied Molecular Transport, Argenx, Biocryst, Bionomics, Calliditas, Circassia, G1 Therapeutics, Humanigen, Pliant, Sareum.

Med-tech firms raising money in public or private financings, including: Livongo Health, Mitesco, Si-Bone.

Biopharmas raising money in public or private financings, including: Adaptimmune, Allogene, Baudax Bio, Biolinerx, Calliditas, Cleveland Biolabs, Nabriva.

Med-tech firms raising money in public or private financings, including: Digirad, Genetic Technologies, Hamilton Thorne.

Biopharmas raising money in public or private financings, including: Arcus, Genetic Technologies, Iovance, Legend Biotech, Marinus, Mersana, Palvella.

Med-tech firms raising money in public or private financings, including: Boston Scientific, Ginkgo Bioworks, Hemaflo Therapeutics, Illumina, Nuvasive, Penumbra, Syapse.

Biopharmas raising money in public or private financings, including: Arcus, Arena, Argenx, Axonis, Biocryst, Caladrius, Genprex, Geron, Hemaflo, Iovance, Mersana, Viela Bio, Xbrane.